Phase 1 Anaemia Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Completed
Phase 1
Open-Label, Randomized, Fasted, Single Oral Dose, Crossover Trial to Assess the Relative Bioavailability of FP-045 and its Metabolite AD-835 After Single Doses of FP-045 2 X 75 mg Capsules (Test Drug) Compared to 150 mg Reconstituted FP-045 Drug Substance Liquid Formulation (Reference Drug) in Healthy Male Participants
Fanconi anaemia
Foresee Pharmaceuticals Co., Ltd.8 enrolled1 locationACTRN12623000148673
Completed
Phase 1
A randomized, double-blind, placebo-controlled dose-escalation study of AND017 capsules in healthy subjects following oral single and multiple dose administration
Anaemia
BalanceBio Pty Ltd78 enrolled1 locationACTRN12620000725965
Completed
Phase 1
Pharmacokinetic study of two orally formulated modified release tablets of Ferrous Sulfate 325mg and Sodium Ascorbate 562.4 mg in healthy volunteers under fasting and fed conditions.
Anaemia
AFT Pharmaceuticals Ltd.24 enrolled1 locationACTRN12619000171112